Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Tyra Biosciences, Inc. (TYRA) had Return on Equity of -8.70% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-28.15M |
|
-- |
|
-- |
|
$31.85M |
|
$-31.85M |
|
$3.70M |
|
$-28.15M |
|
$-28.15M |
|
$-28.15M |
|
$-28.15M |
|
$-28.15M |
|
$-28.15M |
|
$-31.85M |
|
$-31.71M |
|
59.34M |
|
59.34M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$324.57M |
|
$1.52M |
|
$18.91M |
|
$343.48M |
|
$14.25M |
|
-- |
|
$5.70M |
|
$19.94M |
|
$323.53M |
|
$323.53M |
|
$323.53M |
|
53.09M |
|
| Cash Flow Statement Financials | |
$-25.46M |
|
$32.03M |
|
$2.19M |
|
$92.97M |
|
$101.72M |
|
$8.76M |
|
$6.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-8.70% |
-8.70% |
|
-8.19% |
|
-8.70% |
|
$6.09 |
|
$-0.43 |
|
$-0.43 |
|